Propiedad y actividad de insiders de Nautilus Biotechnolgy, Inc. (NAUT): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $0.97 |
| Capitalización | $124M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-06-18 | Posard Matthew L. | A-Award | 45,000 | $103K |
| 2026-06-18 | NAZEM FARZAD | A-Award | 45,000 | $103K |
| 2026-06-18 | Akinsanya Karen | A-Award | 45,000 | $103K |
| 2026-06-18 | McIlwain Matthew S | A-Award | 45,000 | $103K |
| 2026-06-18 | Epperly Melissa B, | A-Award | 45,000 | $103K |
| 2026-06-02 | AH Equity Partners Bio II, L.L.C. | S-Sale | 4,615,974 | $10.8M |
| 2026-06-02 | AH Equity Partners Bio II, L.L.C. | S-Sale | 384,026 | $902K |
| 2026-03-04 | Patel Sujal M | P-Purchase | 25,000 | $65K |
| 2026-03-02 | Mowry Anna | A-Award | 160,000 | $371K |
| 2026-03-02 | Mallick Parag | A-Award | 280,000 | $650K |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $1.2M | $595000 | $36.6M | $185.6M | $114.5M | $19.4M | $27.6M | $12.4M |
| Inversiones a Corto | $144.49B | $16.1M | $40.1M | $160.1M | $69.9M | $154.0M | $102.2M | $91.0M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $1.3M | $17.0M | $77.7M | $349.2M | $187.2M | $176.8M | $132.8M | $106.0M |
| Inmovilizado Material | 0 | $1.1M | $6.2M | $31.9M | $32.6M | $36.9M | $32.3M | $31.2M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $145.8M | $18.5M | $85.0M | $398.4M | $350.1M | $305.6M | $242.7M | $191.1M |
| Cuentas por Pagar | 0 | $289000 | $470000 | $1.7M | $1.3M | $1.6M | $987000 | $943000 |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $5000 | $490000 | $3.0M | $5.8M | $6.8M | $9.1M | $7.6M | $8.0M |
| Deuda a Largo | $5.0M | $275.0M | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $140.8M | $490000 | $114.7M | $34.9M | $35.1M | $40.2M | $34.0M | $34.1M |
| Reservas | $626600 | -$14.7M | -$30.3M | -$80.6M | -$138.6M | -$202.2M | -$273.0M | -$332.0M |
| Patrimonio Neto | $5.0M | $18.1M | -$29.7M | $363.6M | $314.9M | $265.4M | $208.7M | $157.0M |
| Deuda Total | $5.0M | $275.0M | $4.8M | $30.0M | $30.3M | $34.6M | $30.5M | $30.0M |
| Deuda Neta | -$144.48B | $258.3M | -$72.0M | -$315.7M | -$154.1M | -$138.8M | -$99.4M | -$73.4M |
| Capital Circulante | $1.3M | $16.5M | $74.6M | $343.4M | $180.4M | $167.7M | $125.2M | $98.0M |
Salud financiera
| Deuda / Patrimonio | 0.21 |
| Ratio corriente | 10.14 |
Rentabilidad
| Rentabilidad sobre capital | -37.58% |
| Rentabilidad sobre capital invertido | -39.50% |
| Rentabilidad sobre activos | -34.55% |
| Margen bruto | -919.47% |
| Margen operativo | -33043.68% |
| Margen neto | -29747.89% |
Empresas relacionadas: ARCT · ASMB · ENTA · FHTX · HUMA · IMRX · PYXS
Explorar sector: Healthcare · Biotechnology
Más secciones de NAUT: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones